Navigation Links
FDA Approves Shire's FIRAZYR® (icatibant injection) for Acute Attacks of Hereditary Angioedema (HAE)
Date:8/25/2011

erse reactions reported in at least 1% of patients included fever, transaminase increase, dizziness, and rash.  

Full U.S. prescribing information for FIRAZYR will be available at http://www.FIRAZYR.com. For more information about HAE visit http://www.haea.org. Prescribing information may differ between countries. Please consult your local prescribing information.

Notes to editors

SHIRE PLC

Shire's strategic goal is to become the leading specialty biopharmaceutical company that focuses on meeting the needs of the specialist physician.  Shire focuses its business on attention deficit hyperactivity disorder, human genetic therapies, gastrointestinal diseases and regenerative medicine, as well as opportunities in other therapeutic areas to the extent they arise through acquisitions.  Shire's in-licensing, merger and acquisition efforts are focused on products in specialist markets with strong intellectual property protection and global rights.  Shire believes that a carefully selected and balanced portfolio of products with strategically aligned and relatively small-scale sales forces will deliver strong results.

For further information on Shire, please visit the Company's website: http://www.shire.com.

"SAFEHARBOR" STATEMENT UNDER THE PRIVATE SECURITIES LITIGATION REFORM ACT OF 1995

Statements included herein that are not historical facts are forward-looking statements. Such forward-looking statements involve a number of risks and uncertainties and are subject to change at any time. In the event such risks or uncertainties materialize, the Company's results could be materially adversely affected. The risks and uncertainties include, but are not limited to, risks associated with: the inherent uncertainty of research, development, approval, reimbursement, manufacturing and commercialization of th
'/>"/>

SOURCE Shire plc
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6

Related biology technology :

1. USDA Approves Syngenta and John Deere for Broadened Biotechnology Endorsement for Corn Crop Insurance
2. FDA Approves ALOXI(R) (Palonosetron HCl) Capsules for Prevention of Acute Chemotherapy-induced Nausea and Vomiting
3. FDA Approves Fougeras Clotrimazole Cream USP 1%
4. FDA Approves AstraZenecas SEROQUEL XR(R) for the Treatment of Bipolar Depression and Bipolar Mania
5. FDA Approves Orphan Drug Status for Revolutionary Cancer Drug for Children
6. FDA Approves Astellas Vaprisol(R) (Conivaptan Hydrochloride Injection) Premixed in 5% Dextrose for the Treatment of Hyponatremia
7. FDA Approves Durameds LoSEASONIQUE(R) Oral Contraceptive
8. FDA Approves Additional Indication for Norditropin(R) for Small for Gestational Age (SGA) in Children
9. FDA Approves Ranexa(R) for First Line Anti Anginal Use and Adds New Claims for Reduction of Ventricular Arrhythmias, Bradycardia, New Atrial Fibrillation and HbA1c
10. FDA Approves Boston Scientifics Apex(TM) PTCA Dilatation Catheter
11. AUDIO from Medialink and GlaxoSmithKline: FDA Approves Boostrix for Adults
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... (PRWEB) May 23, 2013 The maker ... all types of inventions. They focus on learning practical ... this community gravitate toward bringing their ideas to life ... Biology Movement, works on making projects using biology. Glowing ... of plants to make them glow with bioluminescence genes, ...
(Date:5/23/2013)... Pa. , May 23, 2013 ... research and advisory firms for specialized biopharmaceutical issues, ... hepatologists, and infectious disease specialists reported that in ... patients (e.g., intentionally delaying treatment) in anticipation of ... than six months ago, when only 6 percent ...
(Date:5/23/2013)... 2013 Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" ... host a teleconference to discuss its First Quarter 2013 ... teleconference information is provided below: Date: Thursday, ... (EDT) Dial-in: (800) 875-3456 (U.S.); (800) 648-0973 ... VS22823 For those unable to participate in ...
(Date:5/23/2013)... African Ancestry , Inc., ... of African descent, today announced new product enhancements ... of all races, myDNAmix determines various ancestries included ... Indigenous Americas (Native American), East Asia, West Sub-Saharan ... , Originally launched in late 2011, the enhanced ...
Breaking Biology Technology:Glowing Plant Releases Maker Kit, Enabling Anyone to Make a Glowing Plant at Home 2The Majority of Physicians that Treat Hepatitis C Virus (HCV) Have Begun "Warehousing" and Preparing Their HCV Patients for the Next Generation of HCV Treatments 2The Majority of Physicians that Treat Hepatitis C Virus (HCV) Have Begun "Warehousing" and Preparing Their HCV Patients for the Next Generation of HCV Treatments 3Pressure BioSciences, Inc. to Discuss First Quarter 2013 Financial Results and Provide Business Update 2AfricanAncestry.com Rolls Out Improved MyDNAMix Admixture Test for People of all Races; Enhancements Increase Accuracy in Estimation of Ancestral Makeup 2AfricanAncestry.com Rolls Out Improved MyDNAMix Admixture Test for People of all Races; Enhancements Increase Accuracy in Estimation of Ancestral Makeup 3
... 27 DHA omega-3 innovator,Martek Biosciences announced today that ... featured in new Ricos(R) Cheese Sauce.,Sold to schools throughout ... of,DHA per serving in the standard foodservice packaging of ... 3.5 oz. single serve cup which contains 50 mg,of ...
... III Development and ... -, NEW YORK, and PRINCETON, N.J., Aug. 27 ... Company (NYSE: BMY ) ("companies"),today announced that they ... research, develop and commercialize DGAT-1,inhibitors, a collaboration first announced ...
... launched today a new 200 mg single-use vial ... who have,adjuvant stage III colon cancer and advanced ... efficiency and safety in the,preparation of the injectable ... mg and 100 mg single- use vials. The ...
Cached Biology Technology:life'sDHA(TM) Featured in New Ricos(R) Cheese Sauce 2life'sDHA(TM) Featured in New Ricos(R) Cheese Sauce 3Pfizer and Bristol-Myers Squibb Finalize Agreement for Worldwide Collaboration on Metabolic Disorders Program 2Pfizer and Bristol-Myers Squibb Finalize Agreement for Worldwide Collaboration on Metabolic Disorders Program 3Pfizer and Bristol-Myers Squibb Finalize Agreement for Worldwide Collaboration on Metabolic Disorders Program 4New 200 mg Vial for Eloxatin(R) (Oxaliplatin Injection) Offers Greater Convenience and Efficiency of Preparation 2New 200 mg Vial for Eloxatin(R) (Oxaliplatin Injection) Offers Greater Convenience and Efficiency of Preparation 3New 200 mg Vial for Eloxatin(R) (Oxaliplatin Injection) Offers Greater Convenience and Efficiency of Preparation 4New 200 mg Vial for Eloxatin(R) (Oxaliplatin Injection) Offers Greater Convenience and Efficiency of Preparation 5New 200 mg Vial for Eloxatin(R) (Oxaliplatin Injection) Offers Greater Convenience and Efficiency of Preparation 6New 200 mg Vial for Eloxatin(R) (Oxaliplatin Injection) Offers Greater Convenience and Efficiency of Preparation 7
(Date:5/22/2013)... to genetic engineering drastically reduces the time and ... the workhorses of biotechnology, scientists are reporting. Published ... the method paves the way for more rapid ... cleanup and other activities. , Keith Shearwin and ... of the genetic material DNA into a bacterium,s ...
(Date:5/22/2013)... scientists provide important new details on how climate change ... May 21 in the Journal of Animal Ecology ... accurate predictions and informing policymakers of how species are ... , "There is a growing recognition among biologists that ... another, and that this is going to have very ...
(Date:5/21/2013)... Biologists have known for a long time that ... isn,t well understood, particularly for plants. But it may ... of Australian National University and the U. S. National ... be published 21 May in the journal Nature ... have faster-changing genomes. , Drawing from a database of ...
Breaking Biology News(10 mins):UCLA life scientists present new insights on climate change and species interactions 2UCLA life scientists present new insights on climate change and species interactions 3UCLA life scientists present new insights on climate change and species interactions 4UCLA life scientists present new insights on climate change and species interactions 5Small but speedy: Short plants live in the evolutionary fast lane 2
... bacteria sticking to surfaces both inside and outside the ... most virulent, antibiotic-resistant infections in humans; however, scientific understanding ... A recent study led by a Syracuse University biologist ... that a complex cascade of enhancer binding proteins (EBPs) ...
... ARLINGTON, Va.The Office of Naval Research (ONR) Global ... defense community members at MAST Europe 2011, June ... science and technology inventions and showcasing the organization,s ... gathers senior leaders from more than 40 countries ...
... and the variety of resources available are the key ... according to a new mathematical model that integrates all ... a process called sympatric speciation. Titled "Factors influencing ... edition of the Journal of Evolutionary Biology . ...
Cached Biology News:Syracuse University biologist discovers key regulators for biofilm development 2Office of Naval Research Global connecting with international naval community at MAST Europe 2011 2The mechanics of speciation 2
These 18x18 square No.1 Corning cover glasses are made from No. 0211 zinc titania glass and are 0.16 to 0.19mm thick....
... hydrophobic cover slips for in situ ... arrays on glass slides., Constant ... do not adsorb probes. , Ready-to-use-Hybri-slips ... use. , Avoid RNA degradation-Hybri-slips are ...
...
The model 55D Rocking Shaker provides the same Reliable quality as the 55S, but double the value. The 55D gives you an additional platform with a height of 3.25 in....
Biology Products: